Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Ovid Therapeutics Q1 EPS $(0.17) Beats $(0.21) Estimate, Sales $148.00K Beat $50.00K Estimate

Author: Benzinga Newsdesk | May 14, 2024 08:19am

Ovid Therapeutics (NASDAQ:OVID) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.21) by 19.05 percent. This is a 10.53 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $148.00 thousand which beat the analyst consensus estimate of $50.00 thousand by 196.00 percent. This is a 123.70 percent increase over sales of $66.16 thousand the same period last year.

Posted In: OVID